News and Press Releases
About the CF Foundation | Public Policy | Research NIH Director Francis Collins and CF Foundation to Brief U.S. Senate on Advancing Disease Research

Cystic Fibrosis Foundation Drug Development Model Spawns More Than 30 Promising Therapies

May 19, 2010 | 3 min read
Research FDA Approves Third Pancreatic Enzyme Product: Pancreaze Delayed-Release Capsules

The U.S. Food and Drug Administration (FDA) has approved PancreazeTM delayed-release capsules, a pancreatic enzyme replacement therapy. This is the third such product to receive approval. Pancreaze is manufactured by Johnson & Johnson.

April 15, 2010 | 1 min read
Research CF Foundation Plays Important Role in Bringing New Inhaled Antibiotic Cayston to Patients

The U.S. Food and Drug Administration approved an important new inhaled antibiotic called Cayston® (aztreonam for inhalation solution) today for the treatment of cystic fibrosis (CF). 

Feb. 22, 2010 | 3 min read